This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jan 20;28(3):e41-2; author reply e43-4.

doi: 10.1200/JCO.2009.26.0612. Epub 2009 Dec 14.

Antitumor effect of somatostatin analogs in neuroendocrine tumors

Yu Jo Chua, Michael Michael, John R Zalcberg, Rod J Hicks, David Goldstein, Winston Liauw, Timothy Price

PMID: 20008618
DOI: 10.1200/JCO.2009.26.0612

Comment

Antitumor effect of somatostatin analogs in neuroendocrine tumors

Yu Jo Chua et al. J Clin Oncol. 2010.

. 2010 Jan 20;28(3):e41-2; author reply e43-4.

doi: 10.1200/JCO.2009.26.0612. Epub 2009 Dec 14.

Authors

Yu Jo Chua, Michael Michael, John R Zalcberg, Rod J Hicks, David Goldstein, Winston Liauw, Timothy Price

PMID: 20008618
DOI: 10.1200/JCO.2009.26.0612

No abstract available

PubMed Disclaimer

Comment on

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.
Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R; PROMID Study Group. Rinke A, et al. J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24. J Clin Oncol. 2009. PMID: 19704057 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.